Berkeley HeartLab Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$195M
Berkeley HeartLab General Information
Description
Developer of cardiovascular disease (CVD) management tools and services focusing on the secondary prevention market. The company offers clinical diagnostic tests for CVD management, including HDL and LDL gradient gel electrophoresis tests, and various genetic tests to clinicians and patients. Its testing technology enables risk characterization with relevant cardiovascular disease tests that help clinicians to develop personalized treatment recommendations, as well as allows for the therapeutic monitoring of a patient's disease.
Contact Information
Website
www.bhlinc.comCorporate Office
- 468 Littlefield Avenue
- South San Francisco, CA 94080
- United States
Corporate Office
- 468 Littlefield Avenue
- South San Francisco, CA 94080
- United States
Berkeley HeartLab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 15-Oct-2007 | $195M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 22-Oct-2004 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series D) | 12-Aug-2004 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 12-Mar-2003 | $850K | $8.74M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series C) | 02-Apr-2002 | $7.89M | $7.89M | Completed | Generating Revenue |
Berkeley HeartLab Patents
Berkeley HeartLab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20090118381-A1 | Separation of high density lipoproteins on polymer monoliths with decreased hydrophobicity | Inactive | 04-Dec-2006 | ||
| WO-2008070680-A1 | Separation of high density lipoproteins on polymer monoliths with decreased hydrophobicity | Inactive | 04-Dec-2006 | ||
| WO-2007092380-A2 | Apolipoprotein e genotyping and accompanying internet-based health management system | Inactive | 06-Feb-2006 | ||
| WO-2007092380-A3 | Apolipoprotein e genotyping and accompanying internet-based health management system | Inactive | 06-Feb-2006 | ||
| US-20070224619-A1 | Includes a blood test that measures an apo e genotype from the patient to generate apo b information; using the information as data tool in designing physical regimen to prevent and/or alleviate cardiovascular disorders | Active | 06-Feb-2006 | C12Q1/6883 |
Berkeley HeartLab Signals
Berkeley HeartLab Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Band of Angels | Angel Group | Minority | ||
| Glynn Capital | Venture Capital | Minority | ||
| Sippl Investments | Venture Capital | Minority | ||
| Steelpoint Capital Partners | PE/Buyout | Minority |
Berkeley HeartLab FAQs
-
When was Berkeley HeartLab founded?
Berkeley HeartLab was founded in 1995.
-
Where is Berkeley HeartLab headquartered?
Berkeley HeartLab is headquartered in South San Francisco, CA.
-
What is the size of Berkeley HeartLab?
Berkeley HeartLab has 10 total employees.
-
What industry is Berkeley HeartLab in?
Berkeley HeartLab’s primary industry is Biotechnology.
-
Is Berkeley HeartLab a private or public company?
Berkeley HeartLab is a Private company.
-
What is the current valuation of Berkeley HeartLab?
The current valuation of Berkeley HeartLab is .
-
What is Berkeley HeartLab’s current revenue?
The current revenue for Berkeley HeartLab is .
-
How much funding has Berkeley HeartLab raised over time?
Berkeley HeartLab has raised $25.4M.
-
Who are Berkeley HeartLab’s investors?
Band of Angels, Glynn Capital, Sippl Investments, and Steelpoint Capital Partners have invested in Berkeley HeartLab.
-
When was Berkeley HeartLab acquired?
Berkeley HeartLab was acquired on 15-Oct-2007.
-
Who acquired Berkeley HeartLab?
Berkeley HeartLab was acquired by Celera Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process